3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations.
By leveraging the power of the immune system to recognize, target, and destroy cancer cells, 3T's technology is advancing the development of next-generation therapies that have the potential to be safer, more effective, and even curative for difficult-to-treat cancers.
Company Details
- Employees
- 28
- Founded
- -
- Address
- 681 Gateway Blvd, South San Francisco,california 94080,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- 3tbiosciences.com
- Keywords
- Manager jobs.
- HQ
- South San Francisco, California
3t Biosciences Questions
3T Biosciences's website is 3tbiosciences.com
3T Biosciences's LinkedIn profile is https://www.linkedin.com/company/3tbiosciences
3T Biosciences has
28 employees.
View email and phone details for 28
employees at 3T Biosciences.
3T Biosciences's industry is
Biotechnology Research
3T Biosciences's top competitors are
Arsenal Biosciences, Inc.,
Firefly Bio,
Allakos Inc,
Asher Biotherapeutics,
Curie.bio,
Dren Bio, Inc.,
Capsida Biotherapeutics,
Allogene Therapeutics,
Vistagen,
Sutro Biopharma, Inc..
3T Biosciences's categories are Biotechnology Research
3T Biosciences's founding year is 2017
